Skip to main content
LISATA THERAPEUTICS, INC. logo

LISATA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LSTA ISIN · US1280583022 LEI · 5493002287F62M3EGQ04 US Manufacturing
Open in API
Filings indexed 1,093 across all filing types
Latest filing 2013-07-19 Director's Dealing
Country US United States of America
Listing US LSTA

About LISATA THERAPEUTICS, INC.

https://www.lisata.com/

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2013-07-19 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 15, 2013, reporting the appointment of Stephen W. Potter as Executive Vice President and his resignation from the Board of Directors. The content focuses on management changes, including details of the employment agreement and compensation. There are no financial statements or earnings data presented. The primary subject is the change in senior management personnel. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 6130 characters, which is sufficient to contain substantive information about the management change rather than a brief announcement. Therefore, the appropriate classification is MANG with high confidence.
2013-07-19 English
OWNERSHIP DOCUMENT
Director's Dealing
2013-07-17 English
OWNERSHIP DOCUMENT
Director's Dealing
2013-07-12 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated July 12, 2013, by NeoStem, Inc. The content focuses on the extension of an employment agreement for a senior officer (Vice President and General Counsel), detailing compensatory arrangements including salary, bonuses, stock options, and severance. This is a clear announcement of a change in senior management personnel and their compensation terms. There are no financial statements or detailed financial performance data included, so it is not an Annual Report, Interim Report, or Earnings Release. The document is not a proxy solicitation, voting results, or a regulatory compliance filing unrelated to management changes. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 4090 characters, which is consistent with a detailed management change announcement rather than a full report or a brief notice.
2013-07-12 English
8-K
Share Issue/Capital Change Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated July 12, 2013, by NeoStem, Inc. The key content is the announcement of a 1-for-10 reverse stock split approved by the Board and stockholders, effective July 16, 2013. The document includes details about the reverse stock split, the filing of the Certificate of Amendment, and a press release announcing the event. There are no financial statements or detailed financial data included, only a corporate action announcement related to capital structure. This fits the category of a Share Issue/Capital Change announcement rather than a full financial report or other categories. The document length is about 4913 characters, which is sufficient to contain substantive information about the capital change event. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2013-07-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.